Educational tool only. Does not confirm eligibility or provide medical advice. Always consult your physician before pursuing any trial.
Find Recruiting Clinical Trials for Lung Cancer
Search NSCLC, SCLC, targeted therapy, and immunotherapy lung cancer trials matched to your subtype and mutation status.
🔍 Search Lung Cancer Trials →About Lung Cancer
Lung cancer is the leading cause of cancer death worldwide. Non-small cell lung cancer (NSCLC) accounts for ~85% of cases and includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. NSCLC treatment is driven by driver mutations (EGFR, ALK, ROS1, KRAS, BRAF) and PD-L1 expression. Small cell lung cancer (SCLC) is treated primarily with chemotherapy and immunotherapy.
What Types of Lung Cancer Clinical Trials Exist?
Lung cancer trials test next-generation targeted agents (EGFR, ALK, KRAS inhibitors), checkpoint inhibitor combinations, antibody-drug conjugates, and novel immunotherapy strategies. Biomarker testing (mutation status, PD-L1) is often required for trial eligibility.
Find Recruiting Lung Cancer Trials Near You
Enter your profile and we'll search ClinicalTrials.gov in real time — matching trials to your age, location, and treatment history. Free, no account required.
Search Lung Cancer Trials →Data from ClinicalTrials.gov · Updated in real time · Educational use only
Frequently Asked Questions
What clinical trials are available for lung cancer?▾
Does my lung cancer mutation status affect trial eligibility?▾
Related Conditions
Data source: All clinical trial information is sourced from ClinicalTrials.gov, the official U.S. registry maintained by the National Library of Medicine. Tidera Health is an independent educational platform and is not affiliated with ClinicalTrials.gov or the National Library of Medicine. Always verify trial details directly with the research coordinator or your physician.